Vitamin D Supplementation and Respiratory Index of Severity in Children (RISC) in Pneumonia

• Status: Completed
• Trial end date: 2016-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Childhood deaths from pneumonia is almost 2000 times higher in developing countries than in developed countries. In 1970, pneumonia was responsible for 9% of all deaths in children under 5 years. This rate was 2% in 2007.

Some studies have shown that supplementing with vitamin D reduces disease of the respiratory tract infection. Some other studies have shown anti-inflammatory effect of vitamin D in cell lines. Studies about the role of vitamin D supplementation in pneumonia in children are inadequate to conclude about its role.

The aim of this study is to determine the efficacy of vitamin D supplementation in Respiratory Index of Severity in Children (RISC) hospitalized clinical outcomes of hospitalized patients with community-acquired pneumonia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hormozgan University of Medical Sciences
• Treatments: Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion criteria

• Aged between 2 months to 6 years

• Definite diagnosis of pneumonia

Exclusion criteria

• Immunocompromised patients

• Airway hypersensitivity or asthma

• allergies

• nasal polyps

• Using inhaled medications to one month prior to the study

• Receiving high doses of vitamin D

• Avoiding to complete informed consent form